Your browser doesn't support javascript.
loading
Integrative genomic and transcriptomic analysis of leiomyosarcoma.
Chudasama, Priya; Mughal, Sadaf S; Sanders, Mathijs A; Hübschmann, Daniel; Chung, Inn; Deeg, Katharina I; Wong, Siao-Han; Rabe, Sophie; Hlevnjak, Mario; Zapatka, Marc; Ernst, Aurélie; Kleinheinz, Kortine; Schlesner, Matthias; Sieverling, Lina; Klink, Barbara; Schröck, Evelin; Hoogenboezem, Remco M; Kasper, Bernd; Heilig, Christoph E; Egerer, Gerlinde; Wolf, Stephan; von Kalle, Christof; Eils, Roland; Stenzinger, Albrecht; Weichert, Wilko; Glimm, Hanno; Gröschel, Stefan; Kopp, Hans-Georg; Omlor, Georg; Lehner, Burkhard; Bauer, Sebastian; Schimmack, Simon; Ulrich, Alexis; Mechtersheimer, Gunhild; Rippe, Karsten; Brors, Benedikt; Hutter, Barbara; Renner, Marcus; Hohenberger, Peter; Scholl, Claudia; Fröhling, Stefan.
Affiliation
  • Chudasama P; Division of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Mughal SS; Division of Applied Bioinformatics, DKFZ and NCT Heidelberg, 69120, Heidelberg, Germany.
  • Sanders MA; Faculty of Biosciences, Heidelberg University, 69120, Heidelberg, Germany.
  • Hübschmann D; Department of Hematology, Erasmus Medical Center, 3015 CN, Rotterdam, The Netherlands.
  • Chung I; Wellcome Trust Sanger Institute, Hinxton, UK.
  • Deeg KI; Division of Theoretical Bioinformatics, DKFZ, 69120, Heidelberg, Germany.
  • Wong SH; Department of Bioinformatics and Functional Genomics, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University and BioQuant Center, 69120, Heidelberg, Germany.
  • Rabe S; Department of Pediatric Immunology, Hematology and Oncology, Heidelberg University Hospital, 69120, Heidelberg, Germany.
  • Hlevnjak M; Research Group Genome Organization and Function, DKFZ and BioQuant Center, 69120, Heidelberg, Germany.
  • Zapatka M; Research Group Genome Organization and Function, DKFZ and BioQuant Center, 69120, Heidelberg, Germany.
  • Ernst A; Division of Applied Bioinformatics, DKFZ and NCT Heidelberg, 69120, Heidelberg, Germany.
  • Kleinheinz K; Division of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Schlesner M; Division of Molecular Genetics, DKFZ, 69120, Heidelberg, Germany.
  • Sieverling L; Division of Molecular Genetics, DKFZ, 69120, Heidelberg, Germany.
  • Klink B; Division of Molecular Genetics, DKFZ, 69120, Heidelberg, Germany.
  • Schröck E; German Cancer Consortium (DKTK), 69120, Heidelberg, Germany.
  • Hoogenboezem RM; Division of Theoretical Bioinformatics, DKFZ, 69120, Heidelberg, Germany.
  • Kasper B; Division of Theoretical Bioinformatics, DKFZ, 69120, Heidelberg, Germany.
  • Heilig CE; Division of Applied Bioinformatics, DKFZ and NCT Heidelberg, 69120, Heidelberg, Germany.
  • Egerer G; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, 01307, Dresden, Germany.
  • Wolf S; NCT Dresden, 01307, Dresden, Germany.
  • von Kalle C; DKTK, 01307, Dresden, Germany.
  • Eils R; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, 01307, Dresden, Germany.
  • Stenzinger A; NCT Dresden, 01307, Dresden, Germany.
  • Weichert W; DKTK, 01307, Dresden, Germany.
  • Glimm H; Department of Hematology, Erasmus Medical Center, 3015 CN, Rotterdam, The Netherlands.
  • Gröschel S; Sarcoma Unit, Interdisciplinary Tumor Center Mannheim, Mannheim University Medical Center, Heidelberg University, 68167, Mannheim, Germany.
  • Kopp HG; Department of Internal Medicine V, Heidelberg University Hospital, 69120, Heidelberg, Germany.
  • Omlor G; Department of Internal Medicine V, Heidelberg University Hospital, 69120, Heidelberg, Germany.
  • Lehner B; Genomics and Proteomics Core Facility, DKFZ, 69120, Heidelberg, Germany.
  • Bauer S; Division of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Schimmack S; German Cancer Consortium (DKTK), 69120, Heidelberg, Germany.
  • Ulrich A; Section for Personalized Oncology, Heidelberg University Hospital, 69120, Heidelberg, Germany.
  • Mechtersheimer G; DKFZ-Heidelberg Center for Personalized Oncology (HIPO), 69120, Heidelberg, Germany.
  • Rippe K; Division of Theoretical Bioinformatics, DKFZ, 69120, Heidelberg, Germany.
  • Brors B; Department of Bioinformatics and Functional Genomics, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University and BioQuant Center, 69120, Heidelberg, Germany.
  • Hutter B; DKFZ-Heidelberg Center for Personalized Oncology (HIPO), 69120, Heidelberg, Germany.
  • Renner M; German Cancer Consortium (DKTK), 69120, Heidelberg, Germany.
  • Hohenberger P; Institute of Pathology, Heidelberg University Hospital, 69120, Heidelberg, Germany.
  • Scholl C; Institute of Pathology, Technical University Munich, 81675, Munich, Germany.
  • Fröhling S; DKTK, 81675, Munich, Germany.
Nat Commun ; 9(1): 144, 2018 01 10.
Article in En | MEDLINE | ID: mdl-29321523
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leiomyosarcoma Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2018 Document type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leiomyosarcoma Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2018 Document type: Article Affiliation country: Germany